For two months, a 17-year-old teenager from El Bolsón, who was diagnosed in 2013 with systemic juvenile idiopathic arthritis (AIJS-Still) and who at the end of 2023 presented a reactivation of his baseline, did not receive the medication indicated by his treating physician. Urged by his son’s illness, the father filed a...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
For two months, a 17-year-old teenager from El Bolsón, who was diagnosed in 2013 with systemic juvenile idiopathic arthritis (AIJS-Still) and who at the end of 2023 presented a reactivation of his baseline, did not receive the medication indicated by his treating physician. Urged by his son’s illness, the father filed a...